FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

781555007: Cemiplimab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3747593016 Cemiplimab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3747594010 Cemiplimab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5589161000241111 cémiplimab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cemiplimab This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Programmed cell death protein 1 inhibitor (disposition) true Inferred relationship Some
Cemiplimab Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Some
Cemiplimab Is a Monoclonal antibody true Inferred relationship Some
Cemiplimab Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Cemiplimab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cemiplimab Inferred relationship Some 1
Product containing only cemiplimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cemiplimab Inferred relationship Some 1
Product containing cemiplimab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cemiplimab Inferred relationship Some 1
Product containing only cemiplimab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cemiplimab Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start